Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
Top Cited Papers
Open Access
- 19 December 2003
- journal article
- inflammation and-innate-immunity
- Published by Wiley in European Journal of Immunology
- Vol. 34 (1) , 251-262
- https://doi.org/10.1002/eji.200324032
Abstract
Oligodeoxynucleotides (ODN) with unmethylated deoxycytidyl‐deoxyguanosine (CpG) dinucleotides (CpG ODN) mimic the immunostimulatory activity of bacterial DNA and are recognized by the Toll‐like receptor 9 (TLR9). CpG ODN of the B‐Class stimulate strong B cell and NK cell activation and cytokine production. The highest degrees of NK stimulation as well as IFN‐α secretion by plasmacytoid DC were found to occur only with A‐Class ODN. A third class of CpG ODN combines the immune effects of A‐ and B‐Class CpG ODN. C‐Class ODN strongly stimulate B cell or NK cell activation and IFN‐α production. In contrast to the A‐Class, the C‐Class is wholly phosphorothioate, has no poly‐G stretches, but has palindromic sequences combined with stimulatory CpG motifs. All classes stimulate TLR9‐dependent signaling, but with strikingly different dose‐response relationships that are quite in contrast to those observed for IFN‐α. Effects similar to those on human cells were observed on mouse splenocytes. In contrast, splenocytes from TLR9‐deficient mice did not show any response to the three CpG ODN classes. In vivo studies demonstrate that C‐Class ODN are very potent Th1adjuvants. C‐Class ODN may represent new therapeutic drugs that combine the effects of A‐ and B‐Class ODN for broad applications in infectious disease or cancer therapy.Keywords
This publication has 33 references indexed in Scilit:
- The adaptor molecule TIRAP provides signalling specificity for Toll-like receptorsNature, 2002
- IRAK-M Is a Negative Regulator of Toll-like Receptor SignalingCell, 2002
- Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartmentsEuropean Journal of Immunology, 2002
- Highly Immunostimulatory CpG-Free Oligodeoxynucleotides for Activation of Human LeukocytesAntisense and Nucleic Acid Drug Development, 2002
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Lack of Immune Stimulation by Immobilized CpG-OligodeoxynucleotideAntisense and Nucleic Acid Drug Development, 1999
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995